The Price Is Not the Company: Japan Rewrites the Boardroom Test for Takeovers

A price is evidence, not a verdict

The most important sentence in METI’s clarification is not that boards may reject a high offer. It is the sentence that makes that freedom expensive: a higher price is generally strong evidence of greater value. A premium materially above another bid often means the buyer expects to create more value. Where two credible buyers seek all the shares, the proposal that maximizes corporate value and the proposal that maximizes shareholders’ gain will normally be the same.

That presumption matters because “corporate value” has a dangerous history as a phrase. It can describe the long-term cash-generating capacity of a business. It can also become fog: a word management invokes when a bidder offers shareholders more than management has delivered. METI attempts to cut through that fog by defining corporate value quantitatively—the discounted present value of future cash flows. People, suppliers, regional relationships, environmental performance, technological security and resilience may all matter, but only when the board can explain how they reasonably affect future cash flows or the discount rate applied to them.

This is not an instruction to put every human relationship into a spreadsheet cell. It is an instruction not to substitute sentiment for causation. If a proposed acquisition would drive away engineers, hollow out a critical supplier network, expose sensitive technology, weaken disaster resilience or force the sale of assets necessary for future growth, those effects can reduce future cash flows or raise risk. If a bidder can improve procurement, distribution, research and capital allocation, those synergies can raise them. The board must examine both sides.

The premium starts the inquiry. It does not end it. A board that walks away from the highest offer must replace the missing price signal with better evidence.

Four numbers that are often confused

METI calls an acquisition “desirable” when it satisfies two tests at once: it enhances corporate value and it secures the common interests of shareholders. The first concerns the size and durability of the economic pie. The second concerns allocation—whether the bidder and shareholders divide the gains on fair terms. A brilliant industrial combination at an unfairly low price fails the second test. A spectacular price funded by a plan that destroys the underlying business may fail the first.

The sincerity gate: which proposals deserve the board’s time?

Not every letter marked “confidential” is a real bid. METI says a proposal merits sincere consideration when it is concrete, has a legitimate purpose and is feasible. A board may probe whether the structure, consideration, conditions and timetable are sufficiently specified; whether the buyer has explained its post-acquisition policy; whether financing is substantiated; whether antitrust or foreign-investment approvals are realistically obtainable; and whether a controlling shareholder essential to the deal is willing to sell.

Purpose also matters. A proposal designed mainly to inflate the share price, disrupt a competitor or extract confidential information need not be treated like a fully financed strategic offer. Yet these are factors for a holistic judgment, not labels a board may manufacture. The guidelines explicitly warn companies not to manipulate the definition of a “sincere proposal” to avoid evaluating an uncomfortable bid.

Once the gate is crossed, the work becomes demanding. Directors should test the buyer’s operating strategy, record and management capability; the source and burden of acquisition finance; regulatory and execution risk; the valuation basis; the timetable; plans for the target’s assets; and the credible timing of claimed value creation. The bidder should answer reasonable questions specifically and, where possible, quantitatively.

The debt hidden behind the premium

A buyer’s offer is paid at closing; the consequences of paying it can remain for years. That is why METI highlights acquisition finance. A highly leveraged transaction may load debt onto the target or depend on its cash flows, leaving the combined company unable to fund the investment plan used to justify the deal. An asset sale may be value-enhancing when it frees capital from a low-return business and redirects it toward growth. The same sale may be destructive if vital factories, patents or distribution assets are liquidated merely to finance the purchase price.

The guidance requires directors to separate those cases. They should ask where the money comes from, where the debt sits, what covenants constrain the business, which assets are expected to be sold and who receives the proceeds. They should compare promised synergies with dis-synergies: lost customers, talent departures, delayed investment, systems disruption, antitrust remedies and integration costs. A bidder’s optimism is not a valuation method.

METI also identifies a harder theoretical exception. A bidder might offer shareholders a very high price by planning to transfer economic value away from employees, suppliers, customers, a local economy or the environment. If that transfer damages the firm’s productive network or future license to operate, today’s premium may be tomorrow’s impairment. But boards cannot merely recite “stakeholders.” They must show a credible economic path from the proposed conduct to cash flows or risk. That discipline is the boundary between stewardship and paternalism.

No Japanese “Revlon duty”

American deal lawyers often ask when a board becomes an auctioneer. Under Delaware’s Revlon doctrine, once a sale or break-up becomes inevitable in specified circumstances, directors’ role changes toward obtaining the best value reasonably available for shareholders. Japan’s guidelines deliberately do not impose an equivalent rule that commands the board to choose the highest bidder once a company is “for sale.”

Even after deciding to sell, a Japanese board continues to judge whether the transaction enhances corporate value. It should still seek better terms, remove coercive features and explore competing proposals. In normal conditions, that process should cause the highest-value and highest-price bid to converge. Exceptionally, after reasonable efforts, the board may endorse a lower bid it believes creates more value.

That is not the last word. Shareholders may tender into the higher offer anyway. METI’s framework preserves a crucial separation: the board recommends and explains; the owners choose. The ministry’s soft-law guidance is not itself a statute and is not intended to define directors’ fiduciary duties. Following it should reduce legal risk, but failing to perform every suggested best practice does not automatically create liability.

How Japan built a market that once scarcely existed

To understand why this clarification is so sensitive, return to the ownership structure of postwar Japan. Listed companies were embedded in networks of main banks, suppliers, customers and affiliated corporations that held one another’s shares. These “stable shareholders” were not merely passive investors. Their holdings strengthened commercial ties and insulated management from short-term market pressure—and from unwanted control contests.

The system weakened after the asset bubble burst. Banks under capital and balance-sheet pressure sold equities rapidly. Bank of Japan research puts the value-based cross-shareholding ratio at 18.0% in fiscal 1990 and 7.4% by fiscal 2002. OECD research shows city and regional banks, which had owned more than one-fifth of the stock market during parts of 1975–85, fell to 2.9% by 2012. Operating companies retained substantial strategic holdings, but the fortress had opened.

The opening produced culture shock. In 2005, internet company Livedoor used off-hours market trading to build a large position in Nippon Broadcasting System, prompting a battle over warrants issued to Fuji Television. In 2006, Oji Paper made an unsolicited offer for Hokuetsu Paper. In 2007, U.S. fund Steel Partners bid for Bull-Dog Sauce; shareholders approved discriminatory warrants and the Supreme Court allowed the defense, emphasizing shareholder judgment rather than managerial self-preservation.

Government guidance of that era reflected the problem arriving at the gate. METI and the Ministry of Justice issued takeover-defense guidelines in 2005, followed by a 2008 report. Poison-pill plans multiplied. RIETI counted defenses at 47 companies in fiscal 2005, 150 in fiscal 2006 and 362 by June 2007—about one in seven companies on the Tokyo Stock Exchange at the time.

The old Japanese problem was how to defend a company from an unwelcome buyer. The new problem is how to make directors prove that the company is worth defending on the terms they claim.

From defense to discipline

The next decade changed who was expected to ask questions. The Stewardship Code arrived in 2014, telling institutional investors to engage as responsible owners. The Corporate Governance Code followed in 2015, calling for transparent, fair, timely and decisive decision-making, sustainable growth and higher medium- to long-term corporate value. Revisions pressed companies to explain strategic shareholdings and strengthen independent oversight.

Then the Tokyo Stock Exchange made valuation impossible to ignore. In March 2023 it asked every Prime and Standard Market company to analyze its cost of capital, profitability and market valuation at board level; disclose an improvement plan; execute it; and update investors. The request was not simply to push price-to-book ratios above one. It was to force boards to connect balance sheets, strategy, capital allocation and market judgment.

METI’s August 2023 takeover guidelines were part of that same movement. They replaced an atmosphere centered on defenses with three principles centered on fair contests: acquisitions should enhance corporate value and shareholders’ common interests; shareholder intent should be respected; and useful information should be disclosed transparently. A sincere proposal deserved sincere consideration. A board did not have to sell, but it could no longer dismiss an outsider merely because the approach was unsolicited.

Nidec’s offer for Takisawa Machine Tool became the first prominent application. The bid—announced before the final guidelines and pursued after their release—offered ¥2,600 a share, an approximately 80% premium, and ultimately succeeded. The signal to the market was unmistakable: “unsolicited” no longer meant “illegitimate.” More approaches followed. The competitive fight between KKR and Bain for Fuji Soft pushed the final winning price to ¥9,850 per share. Couche-Tard’s pursuit of Seven & i, though withdrawn in 2025 after a proposed ¥2,600-a-share deal, put the board of one of Japan’s best-known companies under global scrutiny and intensified pressure for a credible standalone strategy.

By 2026, success had created its own ambiguity. Some executives and advisers read the 2023 guidance as an obligation to support the largest number on the table. Others feared that an “always highest” rule would reward overconfident buyers, leveraged extraction or technology loss. Investors, meanwhile, feared that broad invocations of national interest, employees or culture would rebuild the old walls in modern language. METI reopened the study group to draw a narrower line.

The law beneath the soft law also changed

The July interpretation arrived three months after major amendments to the Financial Instruments and Exchange Act took effect on May 1, 2026. Japan lowered the general mandatory tender-offer threshold from one-third to 30% of voting rights and brought on-exchange purchases within the rule. A buyer can no longer quietly cross the control line through ordinary market trades merely because those purchases occur on the exchange.

The large-shareholding regime was also sharpened. Where an investor subject to filing duties has decided on a significant further increase, disclosure of purpose must become more specific about the intended securities, timing, price, quantity, method and counterparty. The legal rules create time, information and equal opportunity around a control transaction. METI’s guidance addresses the different question that remains: what should the target’s board do with that information?

The best case—and the worst

In its best form, the clarification makes board deliberation more serious. Directors will not compare one premium with another in isolation. They will test whether the buyer can finance the deal, obtain approvals and integrate the company; whether the target can still invest after the acquisition; whether confidential technology and critical supply chains are protected; whether apparent synergies survive realistic costs; and whether an independent plan can actually outperform the value implied by the offer.

In its worst form, management will produce a thick presentation full of “human capital,” “regional responsibility” and “economic security,” attach no numbers, declare the bidder incompatible with the company’s purpose and wait for the danger to pass. The ministry expressly warns against that outcome. Qualitative value must be tied to future cash flows or risk. Directors must not emphasize what is hard to measure in order to obscure corporate value or preserve their own positions.

The credibility of any lower-price recommendation will therefore depend on process. Were independent directors genuinely in control? Was there a special committee where conflicts existed? Did advisers test management’s forecasts rather than merely package them? Were valuations and key assumptions disclosed? Did the board negotiate with each bidder, seek alternatives and allow enough time for shareholders to compare? Did it quantify the alleged harm? And after rejecting the offer, did management meet the milestones it had promised?

The obligation that survives rejection

A board’s most consequential work may begin after it says no. METI states that when directors reject a public proposal, they should explain the response and its reasonableness, then execute the independent plan and aim over time to exceed the value implied by the offer. The rejected bid becomes a public benchmark. It cannot be erased from the chart.

This converts “no” from an event into a performance contract. If management argued that retaining a factory, research team or supplier relationship would produce more value, investors can ask whether the promised investment occurred and whether returns followed. If the board said regulatory risk made the bid infeasible, investors can examine how that judgment compared with the evidence. If a higher proposal later succeeds despite the board’s recommendation, the guidance says the recommendation alone is generally not a breach—provided the judgment was sincere and reasonable.

The market will supply its own verdicts. Directors who choose a lower bid will know that shareholders can tender to the higher bidder. Directors who choose independence will know the pre-bid premium is now a visible hurdle. Buyers will know that a headline price does not excuse a weak plan. Each side has something to prove.

Japan’s new argument about ownership

For much of the postwar period, the question “Who should own this company?” was answered inside a web of relationships before it ever reached the market. The unraveling of that web made control contestable. Governance reform made boards more answerable. The 2023 guidelines made unsolicited proposals discussable. The 2026 clarification now confronts the mature version of the problem: a market for corporate control works only if price disciplines management without becoming the sole definition of value.

That balance will never be comfortable. Give price too little weight and corporate value becomes a castle wall. Give it absolute weight and the board becomes a mailroom that forwards the largest cheque. METI’s answer is neither managerial veto nor automatic auction. It is judgment under an evidentiary burden.

A board may choose something other than the highest offer. What it may no longer choose is an unexplained answer.

The two envelopes remain on the table. The number on one is larger. The task is not to pretend otherwise. It is to discover whether that number represents a better company, a better distribution to current owners, a riskier forecast—or some combination of all three. In modern Japan, the board’s authority rests on showing its work, and the shareholders’ authority rests on deciding whether to believe it.